Advanced Heart Failure and Transplant Cardiology · Naples, FL
NPI
1447493275
Since 2009
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
399 9th St N Ste 300
Naples, FL, 34102
Phone (239) 624-4200
Groups this clinician bills Medicare through
Medicare paid, 2024
$230K
2,468 services
Medicare patients, 2024
681
Average age 80
Drug cost, 2024
$15.5M
2,404 prescriptions
Company payments, 2025
$164K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elsy V Navas was code 99233 (hospital e&m - subsequent), 613 times for 191 patients. In total Elsy V Navas billed 2,468 services in 23 codes, and Medicare paid $230K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 613 | 191 | $96.38 | $59K |
| 99215 Office E&M - Established | Office | 597 | 330 | $142.44 | $85K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 347 | 238 | $13.42 | $4,657 |
| 99223 Hospital E&M - Initial | Facility | 239 | 206 | $141.41 | $34K |
| 36415 Venipuncture Blood Collection | Office | 228 | 169 | $8.65 | $1,972 |
| 99205 Office E&M - New | Office | 170 | 170 | $177.08 | $30K |
| 93000 Electrocardiogram | Office | 105 | 98 | $11.33 | $1,189 |
| 99214 Office E&M - Established | Office | 34 | 33 | $98.39 | $3,345 |
| 99222 Hospital E&M - Initial | Facility | 26 | 26 | $100.06 | $2,602 |
| 93451 Percutaneous Transcatheterization | Facility | 17 | 16 | $99.45 | $1,691 |
| 99205 Office E&M - New | Facility | 13 | 13 | $140.32 | $1,824 |
By year: 2022 $192K for 1,818 services; 2023 $215K for 2,170 services; 2024 $230K for 2,468 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 228 | 169 | $8.65 | $1,972 |
Medicare prescription drug claims, 2024
In 2024, the drug Elsy V Navas prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 429 prescriptions and refills. In total Elsy V Navas wrote 2,404 Medicare prescriptions that cost $15.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 429 | 507 | 61 | $11.9M |
| Entresto Sacubitril/Valsartan | 327 | 612 | 86 | $348K |
| Jardiance Empagliflozin | 289 | 587 | 85 | $333K |
| Spironolactone Generic | 187 | 438 | 57 | $1,133 |
| Metoprolol Succinate Generic | 165 | 429 | 66 | $1,673 |
| Furosemide Generic | 132 | 334 | 50 | $728 |
| Eliquis Apixaban | 91 | 185 | 29 | $106K |
| Atorvastatin Calcium Generic | 86 | 229 | 31 | $775 |
| Carvedilol Generic | 71 | 192 | 25 | $706 |
| Farxiga Dapagliflozin Propanediol | 57 | 105 | 21 | $58K |
| Torsemide Generic | 51 | 123 | 23 | $1,347 |
| Potassium Chloride Generic | 43 | 104 | 16 | $1,049 |
| Vyndaqel Tafamidis Meglumine | 37 | 43 | Under 11 | $936K |
| Corlanor Ivabradine Hcl | 31 | 39 | Under 11 | $17K |
| Hydralazine Hcl Generic | 31 | 71 | Under 11 | $515 |
Brand drugs: 1,323 claims; generic drugs: 1,081 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elsy V Navas $164K ($164K in general payments such as food, travel and fees) from 22 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $68K.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 44 | $68K |
| Pfizer Inc. PFE | 23 | $32K |
| Scpharmaceuticals Inc. SCPH | 17 | $20K |
| BridgeBio Pharma, Inc. BBIO | 10 | $15K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $13K |
| Lilly USA, LLC LLY | 6 | $6,760 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $3,842 |
| Edwards Lifesciences Corporation EW | 4 | $2,533 |
| Abiomed JNJ | 6 | $507 |
| Medtronic, Inc. MDT | 6 | $328 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.